A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Purpose

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Condition

  • Hepatocellular Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Male or female patients, age ≥18 years
  2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

Exclusion Criteria

  1. Inability to provide written informed consent

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Banner University Medical Center
Phoenix, Arizona 85006
Contact:
Elena Young
602-255-7553
elenay@email.arizona.edu

More Details

NCT ID
NCT02954094
Status
Recruiting
Sponsor
Target PharmaSolutions, Inc.

Study Contact

Mara Grbic
mgrbic@targetpharmasolutions.com